Clinical Trial Update: "TARGET 2.0 Study": Safety and Performance of the Cardiovalve TR Replacement System [NA]

View source ↗

Summary

The TARGET 2.0 Study is evaluating the safety and performance of the Cardiovalve tricuspid valve replacement system, and the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tricuspid Regurgitation

Drugs mentioned

• Cardiovalve TR Replacement System

Snippet

Sponsor: Cardiovalve Ltd. | Conditions: Tricuspid Regurgitation | NA | Status: RECRUITING